Explore
← New search
Filters:
1
✕
metabric cohort, er+/her2- breast cancer patients (human tumor tissue)
✕
controlled
✕
clear all
1 matching publication(s)
Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a⚑
PMID 35143511 · PLoS One · 2022
L1
48/100
⚑